Active surveillance: minimising treatment while maximising outcomes in testis cancer

被引：0
|
作者：
Conduit, Ciara [1 ,2 ,3 ]
Tran, Ben [1 ,2 ,3 ]
机构：
[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Locked Bag 1,ABecicett St, Melbourne, Vic 8006, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[3] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2023年 / 12卷 / 09期
关键词：
Testicular cancer; survivorship; active surveillance; STAGE-I; TESTICULAR CANCER; SEMINOMA;
D O I：
10.21037/tau-23-364
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：1371 / 1374
页数：4
相关论文
共 50 条
  • [31] Eligibility for active surveillance of prostate cancer and functional outcomes after prostatectomy
    Shepherd, A.
    O'Callaghan, M.
    BJU INTERNATIONAL, 2015, 115 : 33 - 33
  • [32] Pathological outcomes in men with prostate cancer who are eligible for active surveillance
    Wang, Shu-Chi
    Chen, Cheng-Che
    Yang, Cheng-Kuang
    Hung, Siu-Wan
    Jan, Yee-Jee
    Ou, Yen-Chuan
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (04) : 348 - 351
  • [33] Impact of compliance on outcomes for patients on active surveillance for prostate cancer.
    Detsky, Jay
    Ghiam, Alireza Fotouhi
    Mamedov, Alexandre
    Commisso, Kristina
    Commisso, Angela
    Klotz, Laurence
    Liu, Stanley K.
    Loblaw, Andrew
    Vesprini, Danny
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [34] Medium-term Outcomes of Active Surveillance for Localised Prostate Cancer
    Selvadurai, Elizabeth D.
    Singhera, Mausam
    Thomas, Karen
    Mohammed, Kabir
    Woode-Amissah, Ruth
    Horwich, Alan
    Huddart, Robert A.
    Dearnaley, David P.
    Parker, Chris C.
    EUROPEAN UROLOGY, 2013, 64 (06) : 981 - 987
  • [35] Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Cooperberg, Matthew R.
    Cowan, Janet E.
    Hilton, Joan F.
    Reese, Adam C.
    Zaid, Harras B.
    Porten, Sima P.
    Shinohara, Katsuto
    Meng, Maxwell V.
    Greene, Kirsten L.
    Carroll, Peter R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 228 - 234
  • [36] Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer
    Detsky, Jay S.
    Ghiam, Alireza Fotouhi
    Mamedov, Alexandre
    Commisso, Kristina
    Commisso, Angela
    Zhang, Liying
    Liu, Stanley
    Klotz, Laurence
    Loblaw, Andrew
    Vesprini, Danny
    JOURNAL OF UROLOGY, 2020, 204 (05): : 934 - 940
  • [37] Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort
    Cullen, Jennifer
    Brassell, Stephen A.
    Chen, Yongmei
    Porter, Christopher
    L'Esperance, James
    Brand, Timothy
    McLeod, David G.
    PROSTATE CANCER, 2011, 2011
  • [38] Outcomes for Men with Intermediate-risk Prostate Cancer on Active Surveillance
    Courtney, P. T.
    Deka, R.
    Cherry, D. R.
    Nelson, T. J.
    Luterstein, E.
    Salans, M. A.
    Yip, A. T. T.
    Nalawade, V.
    Parsons, J. K.
    Kader, K.
    Stewart, T. F.
    Rose, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S121 - S122
  • [39] PROSTATE CANCER In favour of active surveillance-functional outcomes matter
    Pfister, David
    NATURE REVIEWS UROLOGY, 2013, 10 (05) : 263 - 265
  • [40] PATHOLOGIC OUTCOMES IN MEN MEETING CRITERIA FOR ACTIVE SURVEILLANCE OF PROSTATE CANCER
    Conti, Simon
    Dall'Era, Marc
    Fradet, Vincent
    Cowan, Janet E.
    Simko, Jeffery
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 60 - 60
12345